An Option for Bladder Cancer Patients When BCG Fails Them
Release Date: 01/02/2025
Turning Cancer Into Strength: Danny Gereg’s Powerful Comeback
Bladder Cancer Matters
In this powerful and deeply personal episode of Bladder Cancer Matters, host Rick Bangs talks with survivor and advocate Danny Gereg, who shares how a shocking 2023 bladder cancer diagnosis became the catalyst for a total life transformation. Once diabetic, alcoholic, and obese, Danny rebuilt his body and spirit—losing over 100 pounds, reclaiming his health, and finding purpose as a voice for others navigating the challenges of cancer, sexuality, and recovery. With candor and humor, he discusses the physical and emotional realities of treatment, the life-changing support of his wife, and how...
info_outline
Transforming Bladder Cancer Care: A Conversation with Dr. Mark Schoenberg
Bladder Cancer Matters
In this episode of Bladder Cancer Matters, host and survivor Rick Bangs sits down with Dr. Mark Schoenberg—renowned urologist and Chief Medical Officer at UroGen® Pharma—for a wide-ranging conversation about the evolution of bladder cancer research, treatment, and patient advocacy. Dr. Schoenberg shares the story behind BCAN’s founding, the early challenges of raising awareness, and the innovations that are reshaping care today, including the development of non-surgical therapies like ZUSDURI™ (mitomycin) for intravesical solution, a prescription medicine used to treat adults with a...
info_outline
When a Cancer Doctor Becomes the Bladder Cancer Patient
Bladder Cancer Matters
In this powerful episode of , host Rick Bangs welcomes Dr. Rick Zera, a retired surgical oncologist who spent decades treating breast cancer before unexpectedly becoming a bladder cancer patient himself. Dr. Zera shares his remarkable story of moving from the operating room to the patient’s chair, beginning with a shocking diagnosis of an extremely rare and aggressive bladder cancer. He speaks candidly about the delays and frustrations he faced in getting timely care, the difficult choices between treatment options, and the emotional toll of navigating his own cancer journey after a career...
info_outline
Celebrating 100 Episodes: A Family’s Bladder Cancer Journey
Bladder Cancer Matters
Bladder Cancer Matters just hit a huge milestone—our 100th episode! In this special 20th anniversary edition of our Partners in Progress series, host Rick Bangs talks with Drew and Erica, whose mom Fran is living with bladder cancer, about what it means to be a caregiver. From music-filled car rides to difficult treatment decisions, they share honest, heartfelt stories of resilience, laughter, hope and the power of family. 💙 Tune in and be inspired by their journey—and celebrate this milestone with us!
info_outline
Bladder Cancer Medical Bills: A Toxic Side Effect
Bladder Cancer Matters
In this powerful episode of Bladder Cancer Matters, host Rick Bangs sits down with Dr. Ruchika Talwar, a leading urologic oncologist and health policy expert, to tackle the growing issue of financial toxicity in bladder cancer care. With candid insights and clear explanations, Dr. Talwar breaks down the hidden and rising costs patients face—from co-pays and lost wages to caregiver burdens and high drug prices—and explains why bladder cancer is the most expensive cancer per patient in the U.S. Listeners will gain practical tips to navigate the system, avoid financial pitfalls, and advocate...
info_outline
Managing Life After Neobladder: Incontinence Tips That Help
Bladder Cancer Matters
In this powerful episode of , host and survivor Rick Bangs sits down with Dr. Brian Zheng of Brigham and Women’s Hospital and Harvard Medical School to explore a deeply personal yet often overlooked topic: life after a radical cystectomy. Dr. Zheng shares candid insights on the different types of incontinence, how they uniquely affect men and women, and—most importantly—practical tips and treatment options that can dramatically improve quality of life. From behavioral changes and physical therapy to products, medications, and surgical solutions, this episode arms listeners with...
info_outline
Innovating Bladder Cancer Care with CG Oncology
Bladder Cancer Matters
In this compelling episode of , host Rick Bangs sits down with Dr. Vijay Kasturi, Chief Medical Officer at , for a must-hear conversation that blends science, heart, and hope. From the personal loss that fuels his passion to the groundbreaking clinical trials underway for Cretostimogene—an innovative investigational therapy targeting non-muscle invasive bladder cancer—Dr. Kasturi offers a behind-the-scenes look at how CG Oncology is working to change the game for patients. Whether you're a patient, caregiver, clinician, or advocate, this episode delivers crucial insights into new horizons...
info_outline
From Misdiagnosis to Advocacy: Deb’s UTUC Journey
Bladder Cancer Matters
In this powerful episode of Bladder Cancer Matters, host Rick Bangs talks with Deb Wells, a survivor of high-grade upper tract urothelial cancer (UTUC), who shares her emotional and eye-opening journey to diagnosis and treatment. After months of misdiagnoses and repeated ER visits, Deb finally learned the truth behind her symptoms—an experience that will resonate with many bladder cancer patients, especially women. She opens up about the importance of being an informed patient, finding the right medical team, and leaning on a support system when facing uncertainty. Deb’s story is both...
info_outline
Saving the Bladder: Risks, Realities, and Rare Exceptions
Bladder Cancer Matters
Can you really just take out part of the bladder? It’s one of the most common questions bladder cancer surgeons hear—and in this episode of Bladder Cancer Matters, host Rick Bangs sits down with renowned urologic oncologist Dr. John Gore to break it all down. From TURBTs to partial cystectomies, they explore when bladder-sparing approaches are appropriate, what the real risks and benefits are, and how treatment choices affect long-term outcomes. Whether you’re a patient, caregiver, or advocate, this episode is packed with the kind of honest, expert insight that can help you make more...
info_outline
Prehab for Bladder Cancer Patients Explained
Bladder Cancer Matters
Can personalized exercise improve recovery after bladder cancer surgery? In our latest Bladder Cancer Matters podcast, host Rick Bangs talks with Dr. Sarah Psutka about her groundbreaking BCAN-funded clinical trial, Get Moving. This innovative study explores how tailored, app-based exercise programs can help patients undergoing major surgery for bladder or upper tract urothelial cancer recover faster and feel better. From reducing frailty to rebuilding strength at home using just a smartphone and a Fitbit, this episode dives deep into the science—and heart—behind helping patients thrive.
info_outlineDiscover how groundbreaking advancements in bladder cancer care are transforming lives in our latest Bladder Cancer Matters podcast episode!
Host Rick Bangs kicks off BCAN’s 20th anniversary "Partners in Progress" series with Karishma Parikh of Ferring Pharmaceuticals.
Learn about Adstiladrin, an innovative gene therapy offering hope and bladder preservation for some patients with high-risk, BCG-unresponsive bladder cancer. With a 96% success rate in preventing progression to muscle-invasive cancer and life-changing patient stories, this episode is packed with insights into how Ferring is driving innovation, supporting patient needs, and reshaping the future of bladder cancer care. Tune in now and be inspired!
=====
About Adstiladrin:
INDICATION
ADSTILADRIN is a treatment for adults who have all the following:
- High-risk non–muscle-invasive bladder cancer (NMIBC)
- Cancer that is not responding to Bacillus Calmette-Guérin (BCG) therapy
- Carcinoma in situ (CIS) with or without other high-grade tumors
IMPORTANT SAFETY INFORMATION
Who should not receive ADSTILADRIN?
Do not receive ADSTILADRIN if you have a sensitivity to interferon alfa or any of its components.
What is the most important information I should know about ADSTILADRIN?
Individuals who are immunosuppressed or immune-deficient should not prepare, administer, receive or come into contact with ADSTILADRIN.
What should I tell my healthcare provider?
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of ADSTILADRIN?
The most common side effects of ADSTILADRIN include:
Urinary discharge, fatigue, bladder spasm, urgency to urinate, and blood in your urine.
These are not all the possible side effects of ADSTILADRIN. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-332-1088. You may also contact Ferring Pharmaceuticals at 1-888-FERRING.
What other information should I know about using ADSTILADRIN?
For two days following treatment, voided urine should be disinfected for 15 minutes with an equal volume of bleach before flushing.
For more important information, call 1-888-337-7464.
Please see full Prescribing Information.